NVS Novartis AG | US66987V1098
| Metric | Current | 30.06.2026 | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|---|
| Market Cap | 294.629.801.984 | 297.880.032.045,01 | 291.461.047.653,75 | 263.076.862.666,58 | 246.065.911.880,8 |
| Enterprise Value | 336.429.809.664 | 339.278.032.045,01 | 331.582.047.653,75 | 287.017.862.666,58 | 268.531.911.880,8 |
| Trailing P/E | 23,42 | 23,35 | 21,54 | 25,35 | 30,88 |
| Forward P/E | 15,79 | - | - | - | - |
| Price to Sales | 5,2 | 5,25 | 5,15 | 6,11 | 8,43 |
| Price to Book | 7,68 | 7,17 | 7,57 | 5,7 | 5,55 |
| EV/Revenue | 5,93 | 5,98 | 5,86 | 6,67 | 9,2 |
| EV/EBITDA | 14,57 | 15,11 | 14,8 | 16,89 | 22,53 |